
U.S. federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.
from CBC | Health News https://ift.tt/3p1quCR
Aucun commentaire:
Enregistrer un commentaire